Gut barrier dysfunction in the Apc Min/+ mouse model of colon cancer cachexia

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 12, 2011, Pages 1601-1606

  Puppa, Melissa J ^a   White, James P ^a   Sato, Shuichi ^a   Cairns, Mark ^a   Baynes, John W ^a   Carson, James A ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cachexia; Colorectal cancer; Endotoxin; Gut barrier dysfunction; Gut permeability; Inflammation

Indexed keywords

ENDOTOXIN; GLUCOSE; INTERLEUKIN 6; TRIACYLGLYCEROL;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CACHEXIA; CHRONIC INFLAMMATION; COLON CANCER; DISEASE COURSE; ENDOTOXEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERLIPIDEMIA; INSULIN RESISTANCE; INTESTINE FUNCTION DISORDER; INTESTINE POLYP; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CACHEXIA; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENDOTOXINS; GASTROINTESTINAL TRACT; HUMANS; HYPERLIPIDEMIAS; HYPOTHERMIA; INSULIN RESISTANCE; INTERLEUKIN-6; LYMPH NODES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERMEABILITY; TUMOR BURDEN;

ANIMALIA; LIMULUS AMOEBOCYTE;

EID: 80053895112     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.08.010     Document Type: Article

References (44)

1. Inagaki J., Rodriguez V., Bodey G.P. Proceedings: causes of death in cancer patients. Cancer 1974, 33:568-573.
2. Evans W.J., Morley J.E., Argiles J., Bales C., Baracos V., Guttridge D., Jatoi A., Kalantar-Zadeh K., Lochs H., Mantovani G., Marks D., Mitch W.E., Muscaritoli M., Najand A., Ponikowski P., Rossi Fanelli F., Schambelan M., Schols A., Schuster M., Thomas D., Wolfe R., Anker S.D. Cachexia: a new definition. Clin. Nutr. 2008, 27:793-799.
3. Tisdale M.J. Biology of cachexia. J. Natl. Cancer Inst. 1997, 89:1763-1773.
4. Tisdale M.J. Mechanisms of cancer cachexia. Physiol. Rev. 2009, 89:381-410.
5. Palesty J.A., Dudrick S.J. What we have learned about cachexia in gastrointestinal cancer. Dig. Dis. 2003, 21:198-213.
6. McCart A.E., Vickaryous N.K., Silver A. Apc mice: models, modifiers and mutants. Pathol. Res. Pract. 2008, 204:479-490.
7. Yamada Y., Mori H. Multistep carcinogenesis of the colon in Apc(Min/+) mouse. Cancer Sci. 2007, 98:6-10.
8. Baltgalvis K.A., Berger F.G., Pena M.M., Davis J.M., Muga S.J., Carson J.A. Interleukin-6 and cachexia in ApcMin/+ mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R393-R401.
9. Fink M.P., Delude R.L. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit. Care Clin. 2005, 21:177-196.
10. Deitch E.A., Xu D., Kaise V.L. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front. Biosci. 2006, 11:520-528.
11. Lambert G.P. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J. Anim. Sci. 2009, 87:E101-E108.
12. Costantini T.W., Loomis W.H., Putnam J.G., Drusinsky D., Deree J., Choi S., Wolf P., Baird A., Eliceiri B., Bansal V., Coimbra R. Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins. Shock 2009, 31:416-422.
13. Hang C.H., Shi J.X., Li J.S., Wu W., Yin H.X. Alteration of intestinal mucosa structure and barrier function following traumatic brain injury in rats. World J. Gastroenterol. 2003, 9:2776-2781.
14. Caso J.R., Hurtado O., Pereira M.P., Garcia-Bueno B., Menchen L., Alou L., Gomez-Lus M.L., Moro M.A., Lizasoain I., Leza J.C. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R979-R985.
15. Sandek A., Anker S.D., von Haehling S. The gut and intestinal bacteria in chronic heart failure. Curr. Drug Metab. 2009, 10:22-28.
16. Liu H., Li W., Wang X., Li J., Yu W. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas 2008, 36:192-196.
17. Ammori B.J., Leeder P.C., King R.F., Barclay G.R., Martin I.G., Larvin M., McMahon M.J. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J. Gastrointest. Surg. 1999, 3:252-262.
18. Lambert G.P. Intestinal barrier dysfunction, endotoxemia, and gastrointestinal symptoms: the 'canary in the coal mine' during exercise-heat stress?. Med. Sport Sci. 2008, 53:61-73.
19. Marshall J.C. The gut as a potential trigger of exercise-induced inflammatory responses. Can. J. Physiol. Pharmacol. 1998, 76:479-484.
20. Luyer M.D., Buurman W.A., Hadfoune M., Jacobs J.A., Konstantinov S.R., Dejong C.H., Greve J.W. Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-alpha and preserves gut barrier function early after hemorrhagic shock. Shock 2004, 21:65-71.
21. Yang R., Han X., Uchiyama T., Watkins S.K., Yaguchi A., Delude R.L., Fink M.P. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G621-G629.
22. Baltgalvis K.A., Berger F.G., Pena M.M., Davis J.M., Carson J.A. Effect of exercise on biological pathways in ApcMin/+ mouse intestinal polyps. J. Appl. Physiol. 2008, 104:1137-1143.
23. Min/+ mouse. PLos One 2011, 6:e24650.
24. Murphy E.A., Davis J.M., McClellan J.L., Gordon B.T., Carmichael M.D. Curcumin's effect on intestinal inflammation and tumorigenesis in the ApcMin/+ mouse. J Interferon Cytokine Res 2010, 31:219-226.
25. Habicht G.S. Body temperature in normal and endotoxin-treated mice of different ages. Mech. Ageing Dev. 1981, 16:97-104.
26. Huet O., Kinirons B., Dupic L., Lajeunie E., Mazoit J.X., Benhamou D., Vicaut E., Duranteau J. Induced mild hypothermia reduces mortality during acute inflammation in rats. Acta Anaesthesiol. Scand. 2007, 51:1211-1216.
27. Tisdale M.J. Cancer cachexia. Langenbecks Arch. Surg. 2004, 389:299-305.
28. Cook M.G. The size and histological appearances of mesenteric lymph nodes in Crohn's disease. Gut 1972, 13:970-972.
29. Lucey B.C., Stuhlfaut J.W., Soto J.A. Mesenteric lymph nodes seen at imaging: causes and significance. Radiographics 2005, 25:351-365.
30. Deitch E.A., Specian R.D., Berg R.D. Endotoxin-induced bacterial translocation and mucosal permeability: role of xanthine oxidase, complement activation, and macrophage products. Crit. Care Med. 1991, 19:785-791.
31. Go L.L., Healey P.J., Watkins S.C., Simmons R.L., Rowe M.I. The effect of endotoxin on intestinal mucosal permeability to bacteria in vitro. Arch. Surg. 1995, 130:53-58.
32. O'Dwyer S.T., Michie H.R., Ziegler T.R., Revhaug A., Smith R.J., Wilmore D.W. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch. Surg. 1988, 123:1459-1464.
33. Nautiyal K.M., McKellar H., Silverman A.J., Silver R. Mast cells are necessary for the hypothermic response to LPS-induced sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R595-R602.
34. Gouni I., Oka K., Etienne J., Chan L. Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. J. Lipid Res. 1993, 34:139-146.
35. Uchiumi D., Kobayashi M., Tachikawa T., Hasegawa K. Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats. J. Periodontal Res. 2004, 39:120-128.
36. McCowen K.C., Ling P.R., Ciccarone A., Mao Y., Chow J.C., Bistrian B.R., Smith R.J. Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit. Care Med. 2001, 29:839-846.
37. Siebler J., Galle P.R., Weber M.M. The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH. J. Hepatol. 2008, 48:1032-1034.
38. Soler A.P., Miller R.D., Laughlin K.V., Carp N.Z., Klurfeld D.M., Mullin J.M. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999, 20:1425-1431.
39. Kimura Y., Shiozaki H., Hirao M., Maeno Y., Doki Y., Inoue M., Monden T., Ando-Akatsuka Y., Furuse M., Tsukita S., Monden M. Expression of occludin, tight-junction-associated protein, in human digestive tract. Am. J. Pathol. 1997, 151:45-54.
40. Allen D.C., Connolly N.S., Biggart J.D. Mucin profiles in ulcerative colitis with dysplasia and carcinoma. Histopathology 1988, 13:413-424.
41. Gupta S.C., Misra V., Singh P.A., Misra S.P., Srivastava M., Agrawal R. Mucin histochemistry-a simple and effective method for diagnosing premalignant and early malignant lesions of lower gastrointestinal tract. Indian J. Pathol. Microbiol. 1997, 40:327-333.
42. Rahman S.H., Ammori B.J., Holmfield J., Larvin M., McMahon M.J. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J. Gastrointest. Surg. 2003, 7:26-35. discussion 35-26.
43. K.A.Baltgalvis C.J., Berger F.G., Pena M.M., Mark Davis J., White J.P., Carson J.A. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice. J Appl Physiol 2010, 109:1155-1161.
44. Chiu C.J., Scott H.J., Gurd F.N. Intestinal mucosal lesion in low-flow states. II. The protective effect of intraluminal glucose as energy substrate. Arch. Surg. 1970, 101:484-488.